{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:05:05Z","timestamp":1790813105535,"version":"4.1.0"},"reference-count":86,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T00:00:00Z","timestamp":1730505600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jlr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jlr.2024.100695","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T01:50:52Z","timestamp":1730771452000},"page":"100695","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Humanized monoacylglycerol acyltransferase 2 mice develop metabolic dysfunction-associated steatohepatitis"],"prefix":"10.1016","volume":"65","author":[{"given":"J. Jose","family":"Corbalan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranavi","family":"Jagadeesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4708-8009","authenticated-orcid":false,"given":"Karla K.","family":"Frietze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0561-3653","authenticated-orcid":false,"given":"Rulaiha","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace L.","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9984-3056","authenticated-orcid":false,"suffix":"Jr.","given":"Joseph T.","family":"Nickels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jlr.2024.100695_bib1","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jlr.2024.100695_bib2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12902-022-00980-1","article-title":"Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss","volume":"22","author":"Pouwels","year":"2022","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.jlr.2024.100695_bib3","first-page":"1","article-title":"Triglyceride metabolism in the liver","volume":"8","author":"Alves-Bezerra","year":"2017","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.jlr.2024.100695_bib4","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/MOL.0000000000000756","article-title":"Nonalcohol fatty liver disease: balancing supply and utilization of triglycerides","volume":"32","author":"Santos-Baez","year":"2021","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.jlr.2024.100695_bib5","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0163-7827(03)00051-1","article-title":"Enzymes of triacylglycerol synthesis and their regulation","volume":"43","author":"Coleman","year":"2004","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.jlr.2024.100695_bib6","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1194\/jlr.R800018-JLR200","article-title":"Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis","volume":"49","author":"Yen","year":"2008","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2024.100695_bib7","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1194\/jlr.R052902","article-title":"Intestinal triacylglycerol synthesis in fat absorption and systemic energy metabolism","volume":"56","author":"Yen","year":"2015","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2024.100695_bib8","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41569-022-00676-y","article-title":"Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia","volume":"19","author":"Boren","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.jlr.2024.100695_bib9","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41575-021-00472-y","article-title":"Dietary carbohydrates and fats in nonalcoholic fatty liver disease","volume":"18","author":"Yki-Jarvinen","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jlr.2024.100695_bib10","doi-asserted-by":"crossref","first-page":"8512","DOI":"10.1073\/pnas.132274899","article-title":"Identification of a gene encoding MGAT1, a monoacylglycerol acyltransferase","volume":"99","author":"Yen","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jlr.2024.100695_bib11","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.bbrc.2016.05.071","article-title":"Biochemical characterization of human acyl coenzyme A: 2-monoacylglycerol acyltransferase-3 (MGAT3)","volume":"475","author":"Brandt","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jlr.2024.100695_bib12","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1194\/jlr.M600331-JLR200","article-title":"Catalytic properties of MGAT3, a putative triacylgycerol synthase","volume":"48","author":"Cao","year":"2007","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2024.100695_bib13","doi-asserted-by":"crossref","first-page":"18532","DOI":"10.1074\/jbc.M301633200","article-title":"MGAT2, a monoacylglycerol acyltransferase expressed in the small intestine","volume":"278","author":"Yen","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jlr.2024.100695_bib14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cbd.2009.09.004","article-title":"Comparative genomics and proteomics of vertebrate diacylglycerol acyltransferase (DGAT), acyl CoA wax alcohol acyltransferase (AWAT) and monoacylglycerol acyltransferase (MGAT)","volume":"5","author":"Holmes","year":"2010","journal-title":"Comp. Biochem. Physiol. Part D Genomics Proteomics"},{"key":"10.1016\/j.jlr.2024.100695_bib15","doi-asserted-by":"crossref","first-page":"E927","DOI":"10.1152\/ajpendo.00179.2003","article-title":"Human intestinal monoacylglycerol acyltransferase: differential features in tissue expression and activity","volume":"285","author":"Lockwood","year":"2003","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.jlr.2024.100695_bib16","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1194\/jlr.M016840","article-title":"Deficiency of MGAT2 increases energy expenditure without high-fat feeding and protects genetically obese mice from excessive weight gain","volume":"52","author":"Nelson","year":"2011","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2024.100695_bib17","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1194\/jlr.M035493","article-title":"Intestine-specific expression of MOGAT2 partially restores metabolic efficiency in Mogat2-deficient mice","volume":"54","author":"Gao","year":"2013","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2024.100695_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150976","article-title":"Pharmacological inhibition of monoacylglycerol O-acyltransferase 2 improves hyperlipidemia, obesity, and diabetes by change in intestinal fat utilization","volume":"11","author":"Take","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jlr.2024.100695_bib19","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/2211-5463.12778","article-title":"Inhibition of MGAT2 modulates fat-induced gut peptide release and fat intake in normal mice and ameliorates obesity and diabetes in ob\/ob mice fed on a high-fat diet","volume":"10","author":"Mochida","year":"2020","journal-title":"FEBS Open Bio."},{"key":"10.1016\/j.jlr.2024.100695_bib20","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejphar.2015.03.072","article-title":"JTP-103237, a novel monoacylglycerol acyltransferase inhibitor, modulates fat absorption and prevents diet-induced obesity","volume":"758","author":"Okuma","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jlr.2024.100695_bib21","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.cmet.2022.10.007","article-title":"MGAT2 inhibitor decreases liver fibrosis and inflammation in murine NASH models and reduces body weight in human adults with obesity","volume":"34","author":"Cheng","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.jlr.2024.100695_bib22","article-title":"HuR promotes triglyceride synthesis and intestinal fat absorption","volume":"43","author":"Liu","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.jlr.2024.100695_bib23","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.cgh.2014.08.039","article-title":"Effect of weight loss on magnetic resonance imaging estimation of liver fat and volume in patients with nonalcoholic steatohepatitis","volume":"13","author":"Patel","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jlr.2024.100695_bib24","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jacbts.2019.10.008","article-title":"Limitations of animal studies for predicting toxicity in clinical trials: is it time to rethink our current Approach?","volume":"4","author":"Van Norman","year":"2019","journal-title":"JACC Basic Transl. Sci."},{"key":"10.1016\/j.jlr.2024.100695_bib25","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jacbts.2020.03.010","article-title":"Limitations of animal studies for predicting toxicity in clinical trials: Part 2: potential Alternatives to the Use of animals in Preclinical trials","volume":"5","author":"Van Norman","year":"2020","journal-title":"JACC Basic Transl. Sci."},{"key":"10.1016\/j.jlr.2024.100695_bib26","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.jlr.2024.100695_bib27","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1007\/s12328-021-01491-7","article-title":"Efficacy of elafibranor in patients with liver abnormalities especially non-alcoholic steatohepatitis: a systematic review and meta-analysis","volume":"14","author":"Malik","year":"2021","journal-title":"Clin. J. Gastroenterol."},{"key":"10.1016\/j.jlr.2024.100695_bib28","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00535-017-1415-1","article-title":"Current and future pharmacological therapies for NAFLD\/NASH","volume":"53","author":"Sumida","year":"2018","journal-title":"J.\u00a0Gastroenterol."},{"key":"10.1016\/j.jlr.2024.100695_bib29","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.3748\/wjg.v25.i33.4904","article-title":"Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: impact of dietary fat source","volume":"25","author":"Boland","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jlr.2024.100695_bib30","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/iep.12008","article-title":"An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis","volume":"94","author":"Matsumoto","year":"2013","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.jlr.2024.100695_bib31","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1089\/ten.tec.2017.0018","article-title":"A\u00a0modified hydroxyproline assay based on hydrochloric acid in ehrlich's solution accurately measures tissue collagen content","volume":"23","author":"Cissell","year":"2017","journal-title":"Tissue Eng. Part C Methods"},{"key":"10.1016\/j.jlr.2024.100695_bib32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jlr.2024.100695_bib33","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.jlr.2024.100695_bib34","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"10.1016\/j.jlr.2024.100695_bib35","doi-asserted-by":"crossref","first-page":"7815","DOI":"10.1007\/s11033-023-08666-0","article-title":"Biomarkers of liver diseases","volume":"50","author":"Tamber","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.jlr.2024.100695_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2024.103068","article-title":"Unique metabolomics characteristics for distinguishing cirrhosis related to different liver diseases: a systematic review and meta-analysis","volume":"18","author":"Yang","year":"2024","journal-title":"Diabetes Metab. Syndr."},{"key":"10.1016\/j.jlr.2024.100695_bib37","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.artmed.2018.10.004","article-title":"Computational normalization of H&E-stained histological images: progress, challenges and future potential","volume":"95","author":"Azevedo Tosta","year":"2019","journal-title":"Artif. Intell. Med."},{"key":"10.1016\/j.jlr.2024.100695_bib38","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/path.5388","article-title":"Software-assisted decision support in digital histopathology","volume":"250","author":"Huss","year":"2020","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.jlr.2024.100695_bib39","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/PAP.0000000000000256","article-title":"An algorithmic immunohistochemical approach to define tumor type and assign site of origin","volume":"27","author":"Bellizzi","year":"2020","journal-title":"Adv. Anat. Pathol."},{"key":"10.1016\/j.jlr.2024.100695_bib40","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41580-022-00542-2","article-title":"The mechanisms and roles of selective autophagy in mammals","volume":"24","author":"Vargas","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jlr.2024.100695_bib41","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/hep.29742","article-title":"Lipotoxicity induces hepatic protein inclusions through TANK binding kinase 1-mediated p62\/sequestosome 1 phosphorylation","volume":"68","author":"Cho","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jlr.2024.100695_bib42","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nm.3082","article-title":"An inhibitor of the protein kinases TBK1 and IKK-varepsilon improves obesity-related metabolic dysfunctions in mice","volume":"19","author":"Reilly","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.jlr.2024.100695_bib43","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/hepr.13071","article-title":"Formation of p62-positive inclusion body is associated with macrophage polarization in non-alcoholic fatty liver disease","volume":"48","author":"Fukushima","year":"2018","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.jlr.2024.100695_bib44","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41374-018-0177-6","article-title":"Impaired mitophagy triggers NLRP3 inflammasome activation during the progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis","volume":"99","author":"Zhang","year":"2019","journal-title":"Lab Invest."},{"key":"10.1016\/j.jlr.2024.100695_bib45","doi-asserted-by":"crossref","first-page":"17839","DOI":"10.3748\/wjg.v20.i47.17839","article-title":"Elevated free cholesterol in a p62 overexpression model of non-alcoholic steatohepatitis","volume":"20","author":"Simon","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jlr.2024.100695_bib46","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.molcel.2011.07.039","article-title":"Serine 403 phosphorylation of p62\/SQSTM1 regulates selective autophagic clearance of ubiquitinated proteins","volume":"44","author":"Matsumoto","year":"2011","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jlr.2024.100695_bib47","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/cdd.2012.72","article-title":"Ubiquitination and selective autophagy","volume":"20","author":"Shaid","year":"2013","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jlr.2024.100695_bib48","doi-asserted-by":"crossref","first-page":"542","DOI":"10.4161\/auto.4600","article-title":"How to interpret LC3 immunoblotting","volume":"3","author":"Mizushima","year":"2007","journal-title":"Autophagy"},{"key":"10.1016\/j.jlr.2024.100695_bib49","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jlr.2024.100695_bib50","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1369\/0022155415627681","article-title":"TGF-beta\/SMAD pathway and its regulation in hepatic fibrosis","volume":"64","author":"Xu","year":"2016","journal-title":"J.\u00a0Histochem. Cytochem."},{"key":"10.1016\/j.jlr.2024.100695_bib51","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1006\/abio.1994.1042","article-title":"An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct","volume":"216","author":"Abe","year":"1994","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jlr.2024.100695_bib52","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1186\/1756-0500-5-636","article-title":"Quantification of active and total transforming growth factor-beta levels in serum and solid organ tissues by bioassay","volume":"5","author":"Khan","year":"2012","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.jlr.2024.100695_bib53","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0016-5085(03)00907-7","article-title":"Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis","volume":"125","author":"Feldstein","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jlr.2024.100695_bib54","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s10620-014-3167-6","article-title":"Caspase 3 inactivation protects against hepatic cell death and ameliorates fibrogenesis in a diet-induced NASH model","volume":"59","author":"Thapaliya","year":"2014","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.jlr.2024.100695_bib55","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/s41418-018-0111-x","article-title":"Caspases in metabolic disease and their therapeutic potential","volume":"25","author":"Wilson","year":"2018","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jlr.2024.100695_bib56","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ccell.2017.08.010","article-title":"A\u00a0dual role of caspase-8 in triggering and sensing proliferation-associated DNA damage, a key determinant of liver cancer development","volume":"32","author":"Boege","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jlr.2024.100695_bib57","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrgastro.2013.149","article-title":"From NAFLD to NASH to cirrhosis-new insights into disease mechanisms","volume":"10","author":"Wree","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jlr.2024.100695_bib58","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1074\/jbc.M109.074252","article-title":"Adipocyte apoptosis, a link between obesity, insulin resistance, and hepatic steatosis","volume":"285","author":"Alkhouri","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jlr.2024.100695_bib59","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1478-811X-8-31","article-title":"PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration","volume":"8","author":"Chaitanya","year":"2010","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.jlr.2024.100695_bib60","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1101\/gad.291518.116","article-title":"PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes","volume":"31","author":"Gupte","year":"2017","journal-title":"Genes Dev."},{"key":"10.1016\/j.jlr.2024.100695_bib61","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41575-023-00754-7","article-title":"Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment","volume":"20","author":"Llovet","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jlr.2024.100695_bib62","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3892\/mco.2021.2488","article-title":"Serine palmitoyltransferase long chain subunit 3 is associated with hepatocellular carcinoma in patients with NAFLD","volume":"16","author":"Ijuin","year":"2022","journal-title":"Mol. Clin. Oncol."},{"key":"10.1016\/j.jlr.2024.100695_bib63","doi-asserted-by":"crossref","first-page":"46253","DOI":"10.18632\/oncotarget.10086","article-title":"Elevated expression of FABP3 and FABP4 cooperatively correlates with poor prognosis in non-small cell lung cancer (NSCLC)","volume":"7","author":"Tang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jlr.2024.100695_bib64","doi-asserted-by":"crossref","first-page":"433","DOI":"10.4254\/wjh.v13.i4.433","article-title":"Bile acid indices as biomarkers for liver diseases I: diagnostic markers","volume":"13","author":"Alamoudi","year":"2021","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.jlr.2024.100695_bib65","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/toxsci\/kfae029","article-title":"Characterization of individual bile acids in\u00a0vivo utilizing a novel low bile acid mouse model","volume":"199","author":"Taylor","year":"2024","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.jlr.2024.100695_bib66","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jama.2020.2298","article-title":"Nonalcoholic steatohepatitis: a review","volume":"323","author":"Sheka","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jlr.2024.100695_bib67","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: current concepts and future challenges","volume":"16","author":"Anstee","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jlr.2024.100695_bib68","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12876-020-01356-2","article-title":"Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitis","volume":"20","author":"Hansen","year":"2020","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.jlr.2024.100695_bib69","doi-asserted-by":"crossref","first-page":"6037","DOI":"10.1038\/s41598-017-06158-3","article-title":"Genetic variants including markers from the exome chip and metabolite traits of type 2 diabetes","volume":"7","author":"Jager","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jlr.2024.100695_bib70","doi-asserted-by":"crossref","first-page":"R75","DOI":"10.1530\/JOE-14-0024","article-title":"Metabolic profiling in diabetes","volume":"221","author":"Suhre","year":"2014","journal-title":"J.\u00a0Endocrinol."},{"key":"10.1016\/j.jlr.2024.100695_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2021.100973","article-title":"Autophagy in liver diseases: a review","volume":"82","author":"Qian","year":"2021","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.jlr.2024.100695_bib72","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.2147\/JIR.S450471","article-title":"Identification of mitophagy-associated genes for the prediction of metabolic dysfunction-associated steatohepatitis based on interpretable machine learning models","volume":"17","author":"Deng","year":"2024","journal-title":"J.\u00a0Inflamm. Res."},{"key":"10.1016\/j.jlr.2024.100695_bib73","doi-asserted-by":"crossref","DOI":"10.1038\/srep39942","article-title":"Acylated and desacyl ghrelin are associated with hepatic lipogenesis, beta-oxidation and autophagy: role in NAFLD amelioration after sleeve gastrectomy in obese rats","volume":"6","author":"Ezquerro","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jlr.2024.100695_bib74","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1038\/s41598-021-83974-8","article-title":"Beneficial effects of elafibranor on NASH in E3L.CETP mice and differences between mice and men","volume":"11","author":"van den Hoek","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jlr.2024.100695_bib75","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3748\/wjg.v24.i2.179","article-title":"Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis","volume":"24","author":"Tolbol","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jlr.2024.100695_bib76","doi-asserted-by":"crossref","first-page":"9046","DOI":"10.1038\/s41598-019-45178-z","article-title":"Combined obeticholic acid and elafibranor treatment promotes additive liver histological improvements in a diet-induced ob\/ob mouse model of biopsy-confirmed NASH","volume":"9","author":"Roth","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jlr.2024.100695_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.585887","article-title":"Leptin and obesity: role and clinical implication","volume":"12","author":"Obradovic","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.jlr.2024.100695_bib78","first-page":"E6039","article-title":"A\u00a0noncanonical PPARgamma\/RXRalpha-binding sequence regulates leptin expression in response to changes in adipose tissue mass","volume":"115","author":"Zhang","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jlr.2024.100695_bib79","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1476-511X-11-75","article-title":"MGAT2 deficiency ameliorates high-fat diet-induced obesity and insulin resistance by inhibiting intestinal fat absorption in mice","volume":"11","author":"Tsuchida","year":"2012","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.jlr.2024.100695_bib80","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nm.1937","article-title":"Deficiency of the intestinal enzyme acyl CoA:monoacylglycerol acyltransferase-2 protects mice from metabolic disorders induced by high-fat feeding","volume":"15","author":"Yen","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.jlr.2024.100695_bib81","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","article-title":"Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics","volume":"92","author":"Polyzos","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.jlr.2024.100695_bib82","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","article-title":"Pathogenesis of liver fibrosis","volume":"6","author":"Hernandez-Gea","year":"2011","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.jlr.2024.100695_bib83","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.cmet.2017.04.033","article-title":"A\u00a0guide for the design of pre-clinical studies on sex differences in metabolism","volume":"25","author":"Mauvais-Jarvis","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.jlr.2024.100695_bib84","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13293-022-00451-1","article-title":"Female mice exhibit less overall variance, with a higher proportion of structured variance, than males at multiple timescales of continuous body temperature and locomotive activity records","volume":"13","author":"Smarr","year":"2022","journal-title":"Biol. Sex Differ"},{"key":"10.1016\/j.jlr.2024.100695_bib85","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.2337\/diabetes.51.6.1907","article-title":"Female rats do not exhibit free fatty acid-induced insulin resistance","volume":"51","author":"Hevener","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.jlr.2024.100695_bib86","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1475-2891-8-11","article-title":"Differential susceptibility to obesity between male, female and ovariectomized female mice","volume":"8","author":"Hong","year":"2009","journal-title":"Nutr. J."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227524002001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227524002001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T16:27:59Z","timestamp":1735230479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227524002001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":86,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0022227524002001"],"URL":"https:\/\/doi.org\/10.1016\/j.jlr.2024.100695","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Humanized monoacylglycerol acyltransferase 2 mice develop metabolic dysfunction-associated steatohepatitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jlr.2024.100695","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"100695"}}